ESRRA and breast cancer: GREM1-mediated EGFR activation was suggested to enhance the promoter activity of estrogen-related receptor alpha (ERRα), which is predicted to bind to the GREM1 promoter to increase GREM1 expression and drive breast cancer cell proliferation (Park et al. 2020).